chr19-6690971-C-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000064.4(C3):c.3391-244G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 152,022 control chromosomes in the GnomAD database, including 1,010 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.11   (  1010   hom.,  cov: 32) 
Consequence
 C3
NM_000064.4 intron
NM_000064.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.113  
Publications
9 publications found 
Genes affected
 C3  (HGNC:1318):  (complement C3) Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015] 
C3 Gene-Disease associations (from GenCC):
- atypical hemolytic-uremic syndrome with C3 anomalyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- complement component 3 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine
- C3 glomerulonephritisInheritance: AD Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BP6
Variant 19-6690971-C-G is Benign according to our data. Variant chr19-6690971-C-G is described in ClinVar as Benign. ClinVar VariationId is 1178537.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.123  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.105  AC: 16008AN: 151910Hom.:  1009  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
16008
AN: 
151910
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.105  AC: 16018AN: 152022Hom.:  1010  Cov.: 32 AF XY:  0.106  AC XY: 7883AN XY: 74316 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
16018
AN: 
152022
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
7883
AN XY: 
74316
show subpopulations 
African (AFR) 
 AF: 
AC: 
2318
AN: 
41494
American (AMR) 
 AF: 
AC: 
1518
AN: 
15252
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
631
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
389
AN: 
5174
South Asian (SAS) 
 AF: 
AC: 
384
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
1844
AN: 
10542
Middle Eastern (MID) 
 AF: 
AC: 
17
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
8524
AN: 
67958
Other (OTH) 
 AF: 
AC: 
251
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.492 
Heterozygous variant carriers
 0 
 696 
 1393 
 2089 
 2786 
 3482 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 180 
 360 
 540 
 720 
 900 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
279
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.